Clinical Focus ›› 2015, Vol. 30 ›› Issue (2): 157-160.

Previous Articles     Next Articles

Advance in acute myeloid leukemia therapy 2014

Ren Jinhai;Guo Xiaonan;Lin Fengru   

  • Online:2015-02-05 Published:2015-02-05

Abstract: Research in molecular genetics has been instrumental in deciphering the molecular heterogeneity of acute myeloid leukemia(AML),in particular,the new subtypes of core-binding factor AML(CBF-AML)and FLT3 AML have been identified.Many recurrent mutations in

Key words: leukemia;myeloid, gene, antineoplastic combined chemotheray protocols, molecular targeted therapy, prognosis

CLC Number: